ANPEP and malignant colon neoplasm: APN also reduces TNF-α secreted by macrophage and anti-TNF-α drugs have become clinical drugs for IBD for its activities on inhibit the progression of colitis-related colon cancer [42], so APN and its receptor agonists are expected to become one of clinical treatment strategies for IBD.